Why is Windlas Biotech falling/rising?

As of 17-Sep, Windlas Biotech Ltd is experiencing a decline in its stock price, currently at Rs 974.30, which reflects a decrease of Rs 24.7 or 2.47%. The stock has underperformed its sector by 2.51% today and has been on a downward trend for the last two days, accumulating a total drop of 2.57%. Additionally, the stock has shown negative returns over the past week and month, with declines of 1.94% and 6.89%, respectively. Despite generating a positive return of 9.15% over the past year, the stock's recent performance has been hindered by falling investor participation, as evidenced by a significant drop in delivery volume by 50.94% compared to the 5-day average. The stock is trading above its longer-term moving averages but below its shorter-term averages, indicating mixed signals in its price momentum.
In the broader market context, Windlas Biotech's short-term performance contrasts sharply with the Sensex, which has gained 1.56% over the past week and 2.60% over the past month. This divergence highlights the stock's struggle to keep pace with the market, despite its consistent returns over the last three years and a solid financial position characterized by low debt and positive sales growth. The company's recent financial results, including record net sales and profit before tax, suggest underlying strength; however, the high PEG ratio of 3.8 and premium valuation compared to peers may be contributing to investor caution, leading to the current price decline.